In this episode, I’m diving deep into Mast Cell Activation Syndrome, or MCAS, and why it’s such a big topic in the peptide world. If you’ve been around peptides long enough, you’ve probably seen it — certain people react strongly to compounds like CJC, ipamorelin, or other common peptides, and suddenly they’re dealing with flushing, hives, GI distress, tachycardia, or brain fog.

I break down what MCAS actually is, why some people are genetically predisposed, and why others develop it from environmental triggers, infections, autoimmune issues, or nervous system dysregulation. I also explain why traditional antihistamines often fall short — because they treat symptoms, not the upstream immune imbalance.

Then I walk through my comprehensive MCAS stack: LDN, Thymosin Alpha-1, Thymalin, KPV, VIP, PEA, and even GLP-1 receptor agonists. I explain the mechanisms, dosing strategies, when to introduce each one, and how to think about this in phases instead of expecting a magic bullet.

This isn’t a cure-all, but it’s what I’ve seen work coaching hundreds of people. If you’re sensitive to peptides or trying to get back to baseline after reactions, this episode will give you a structured roadmap.

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!

Get the app

Home Top podcasts Popular guests Top books